<DOC>
	<DOCNO>NCT00004091</DOCNO>
	<brief_summary>RATIONALE : Examining biomarkers abnormal cervical cell may improve ability detect cell plan effective treatment . PURPOSE : Diagnostic trial detect specific biomarkers abnormal cervical cell woman abnormal Pap test result .</brief_summary>
	<brief_title>Detection Biomarkers Abnormal Cervical Cells Women With Abnormal Pap Test Results</brief_title>
	<detailed_description>OBJECTIVES : I . Compare detection transferrin receptor , epidermal growth factor receptor , MaTu-MN protein exfoliate cervical epithelial cell woman abnormal Pap test use fluorescent label antibody probe v histology . OUTLINE : Patients undergo Pap test colposcopy . Cervical epithelial cell collect abnormal appear lesion . Cells examine molecular marker use fluorescent antibody test . The presence absence marker compare result Pap test histology cell . PROJECTED ACCRUAL : A total 100 patient accrue study within 6 month .</detailed_description>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis abnormal Pap test , indicate one following : Atypical squamous cell undetermined significance ( ASCUS ) Low grade squamous intraepithelial lesion ( LGSIL ) High grade squamous intraepithelial lesion ( HGSIL ) Visible lesion cervix colposcopy PATIENT CHARACTERISTICS : Age : Any age Performance status : ECOG 04 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Pregnant nursing woman allow PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : No prior pelvic irradiation Surgery : No prior total hysterectomy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>cervical cancer</keyword>
</DOC>